compare semaglutide and tirzepatide vs Tirzepatide vs Semaglutide: Which Weight

These agents have different dosages and half-life, which are summarised in Table 1

(5.8) Adverse Reactions/Side Effects Most common adverse reactions (incidence 5% and at a rate at least twice placebo) in pediatric patients ages 6 to 17 years, and/or adults with ADHD were anorexia, anxiety, decreased appetite, decreased weight, diarrhea, dizziness, dry mouth, irritability, insomnia, nausea, upper abdominal pain, and vomiting

November 27, 2025 0 Comments13 Minutes

The first readout, TRIUMPH-1 (obesity), was reported on 21 May 2026, with 28.3% mean weight loss at 80 weeks in the 12mg cohort (Pharmaceutical Journal)

R.YuanJ